1
|
Charalambous EG, Mériaux SB, Guebels P, Muller CP, Leenen FAD, Elwenspoek MMC, Thiele I, Hertel J, Turner JD. The oral microbiome is associated with HPA axis response to a psychosocial stressor. Sci Rep 2024; 14:15841. [PMID: 38982178 PMCID: PMC11233668 DOI: 10.1038/s41598-024-66796-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 07/03/2024] [Indexed: 07/11/2024] Open
Abstract
Intense psychosocial stress during early life has a detrimental effect on health-disease balance in later life. Simultaneously, despite its sensitivity to stress, the developing microbiome contributes to long-term health. Following stress exposure, HPA-axis activation regulates the "fight or flight" response with the release of glucose and cortisol. Here, we investigated the interaction between the oral microbiome and the stress response. We used a cohort of 115 adults, mean age 24, who either experienced institutionalisation and adoption (n = 40) or were non-adopted controls (n = 75). Glucose and cortisol measurements were taken from participants following an extended socially evaluated cold pressor test (seCPT) at multiple time points. The cohort´s oral microbiome was profiled via 16S-V4 sequencing on microbial DNA from saliva and buccal samples. Using mixed-effect linear regressions, we identified 12 genera that exhibited an interaction with host's cortisol-glucose response to stress, strongly influencing intensity and clearance of cortisol and glucose following stress exposure. Particularly, the identified taxa influenced the glucose and cortisol release profiles and kinetics following seCPT exposure. In conclusion, our study provided evidence for the oral microbiome modifying the effect of stress on the HPA-axis and human metabolism, as shown in glucose-cortisol time series data.
Collapse
Affiliation(s)
- Eleftheria G Charalambous
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg
- Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur Alzette, Luxembourg
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greisfwald, Germany
- Department of Psychology, University of Cyprus, 2109, Nicosia, Cyprus
| | - Sophie B Mériaux
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg
| | - Pauline Guebels
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg
| | - Claude P Muller
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg
| | - Fleur A D Leenen
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg
| | - Martha M C Elwenspoek
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg
| | - Ines Thiele
- School of Medicine, National University of Ireland, Galway, Ireland
- Ryan Institute, National University of Galway, Galway, Ireland
- Division of Microbiology, National University of Galway, Galway, Ireland
- APC Microbiome Ireland, Cork, Ireland
| | - Johannes Hertel
- Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur Alzette, Luxembourg
- German Center for Cardiovascular Diseases (DZHK), Partner Site Greifswald, Greifswald, Germany
| | - Jonathan D Turner
- Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29, rue Henri Koch, 4354, Esch-sur-Alzette, Luxembourg.
| |
Collapse
|
2
|
Charalambous EG, Mériaux SB, Guebels P, Muller CP, Leenen FAD, Elwenspoek MMC, Thiele I, Hertel J, Turner JD. Early-Life Adversity Leaves Its Imprint on the Oral Microbiome for More Than 20 Years and Is Associated with Long-Term Immune Changes. Int J Mol Sci 2021; 22:ijms222312682. [PMID: 34884490 PMCID: PMC8657988 DOI: 10.3390/ijms222312682] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Revised: 11/19/2021] [Accepted: 11/22/2021] [Indexed: 12/12/2022] Open
Abstract
The early-life microbiome (ELM) interacts with the psychosocial environment, in particular during early-life adversity (ELA), defining life-long health trajectories. The ELM also plays a significant role in the maturation of the immune system. We hypothesised that, in this context, the resilience of the oral microbiomes, despite being composed of diverse and distinct communities, allows them to retain an imprint of the early environment. Using 16S amplicon sequencing on the EpiPath cohort, we demonstrate that ELA leaves an imprint on both the salivary and buccal oral microbiome 24 years after exposure to adversity. Furthermore, the changes in both communities were associated with increased activation, maturation, and senescence of both innate and adaptive immune cells, although the interaction was partly dependent on prior herpesviridae exposure and current smoking. Our data suggest the presence of multiple links between ELA, Immunosenescence, and cytotoxicity that occur through long-term changes in the microbiome.
Collapse
Affiliation(s)
- Eleftheria G. Charalambous
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
- Faculty of Science, Technology and Medicine, University of Luxembourg, 2 Avenue de Université, L-4365 Esch-sur-Alzette, Luxembourg
| | - Sophie B. Mériaux
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
| | - Pauline Guebels
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
| | - Claude P. Muller
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
| | - Fleur A. D. Leenen
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
| | - Martha M. C. Elwenspoek
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
| | - Ines Thiele
- School of Medicine, National University of Ireland, H91 YR71 Galway, Ireland; (I.T.); (J.H.)
- Ryan Institute, National University of Galway, H91 TK33 Galway, Ireland
- Division of Microbiology, National University of Galway, H91 TK33 Galway, Ireland
- APC Microbiome Ireland, T12 HW58 Cork, Ireland
| | - Johannes Hertel
- School of Medicine, National University of Ireland, H91 YR71 Galway, Ireland; (I.T.); (J.H.)
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Jonathan D. Turner
- Immune Endocrine and Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health (LIH), 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; (E.G.C.); (S.B.M.); (P.G.); (C.P.M.); (F.A.D.L.); (M.M.C.E.)
- Correspondence: ; Tel.: +352-26970-629
| |
Collapse
|
3
|
Chowdhury S, Fong SS. Leveraging genome-scale metabolic models for human health applications. Curr Opin Biotechnol 2020; 66:267-276. [PMID: 33120253 DOI: 10.1016/j.copbio.2020.08.017] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2020] [Revised: 08/27/2020] [Accepted: 08/31/2020] [Indexed: 02/07/2023]
Abstract
Genome-scale metabolic modeling is a scalable and extensible computational method for analyzing and predicting biological function. With the ongoing improvements in computational methods and experimental capabilities, genome-scale metabolic models (GEMs) are demonstrating utility in addressing human health applications. The initial areas of highest impact are likely to be health applications where disease states involve metabolic changes. In this review, we focus on recent application of GEMs to studying cancer and the human microbiome by describing the enabling methodologies and outcomes of these studies. We conclude with proposing some areas of research that are likely to arise as a result of recent methodological advances.
Collapse
Affiliation(s)
- Shomeek Chowdhury
- Integrative Life Sciences, Virginia Commonwealth University, 1000 West Main Street, Richmond, 23284, VA, USA
| | - Stephen S Fong
- Integrative Life Sciences, Virginia Commonwealth University, 1000 West Main Street, Richmond, 23284, VA, USA; Chemical and Life Science Engineering, Virginia Commonwealth University, 601 West Main Street, Richmond, 23284, VA, USA.
| |
Collapse
|
4
|
Chowdhury S, Fong SS. Computational Modeling of the Human Microbiome. Microorganisms 2020; 8:microorganisms8020197. [PMID: 32023941 PMCID: PMC7074762 DOI: 10.3390/microorganisms8020197] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Revised: 01/23/2020] [Accepted: 01/27/2020] [Indexed: 12/20/2022] Open
Abstract
The impact of microorganisms on human health has long been acknowledged and studied, but recent advances in research methodologies have enabled a new systems-level perspective on the collections of microorganisms associated with humans, the human microbiome. Large-scale collaborative efforts such as the NIH Human Microbiome Project have sought to kick-start research on the human microbiome by providing foundational information on microbial composition based upon specific sites across the human body. Here, we focus on the four main anatomical sites of the human microbiome: gut, oral, skin, and vaginal, and provide information on site-specific background, experimental data, and computational modeling. Each of the site-specific microbiomes has unique organisms and phenomena associated with them; there are also high-level commonalities. By providing an overview of different human microbiome sites, we hope to provide a perspective where detailed, site-specific research is needed to understand causal phenomena that impact human health, but there is equally a need for more generalized methodology improvements that would benefit all human microbiome research.
Collapse
Affiliation(s)
- Shomeek Chowdhury
- Integrative Life Sciences, Virginia Commonwealth University, 1000 West Cary Street, Richmond, VA 23284 USA;
| | - Stephen S. Fong
- Chemical and Life Science Engineering, Virginia Commonwealth University, 601 West Main Street, Richmond, VA 23284, USA
- Correspondence:
| |
Collapse
|
5
|
Gomez A, Nelson KE. The Oral Microbiome of Children: Development, Disease, and Implications Beyond Oral Health. MICROBIAL ECOLOGY 2017; 73:492-503. [PMID: 27628595 PMCID: PMC5274568 DOI: 10.1007/s00248-016-0854-1] [Citation(s) in RCA: 84] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/22/2016] [Accepted: 09/01/2016] [Indexed: 05/05/2023]
Abstract
In the era of applied meta-omics and personalized medicine, the oral microbiome is a valuable asset. From biomarker discovery to being a powerful source of therapeutic targets and to presenting an opportunity for developing non-invasive approaches to health care, it has become clear that oral microbes may hold the answer for understanding disease, even beyond the oral cavity. Although our understanding of oral microbiome diversity has come a long way in the past 50 years, there are still many areas that need to be fine-tuned for better risk assessment and diagnosis, especially in early developmental stages of human life. Here, we discuss the factors that impact development of the oral microbiome and explore oral markers of disease, with a focus on the early oral cavity. Our ultimate goal is to put different experimental and methodological views into perspective for better assessment of early oral and systemic disease at an early age and discuss how oral microbiomes-at the community level-could provide improved assessment in individuals and populations at risk.
Collapse
Affiliation(s)
- Andres Gomez
- Departments of Human Biology and Genomic Medicine, J. Craig Venter Institute, La Jolla, 92037, CA, USA.
| | - Karen E Nelson
- Departments of Human Biology and Genomic Medicine, J. Craig Venter Institute, La Jolla, 92037, CA, USA
| |
Collapse
|
6
|
Ohshima H. Oral Biosciences: The annual review 2014. J Oral Biosci 2015. [DOI: 10.1016/j.job.2014.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Oberhardt MA, Gianchandani EP. Genome-scale modeling and human disease: an overview. Front Physiol 2015; 5:527. [PMID: 25667572 PMCID: PMC4304257 DOI: 10.3389/fphys.2014.00527] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2014] [Accepted: 12/23/2014] [Indexed: 12/11/2022] Open
Affiliation(s)
- Matthew A Oberhardt
- Department of Molecular Microbiology and Biotechnology, Faculty of Life Sciences, School of Computer Sciences, and Sackler School of Medicine, Tel Aviv University Tel Aviv, Israel
| | - Erwin P Gianchandani
- Division of Computer and Network Systems, United States National Science Foundation Arlington, VA, USA
| |
Collapse
|
8
|
Henry LG, Boutrin MC, Aruni W, Robles A, Ximinies A, Fletcher HM. Life in a Diverse Oral Community - Strategies for Oxidative Stress Survival. J Oral Biosci 2014; 56:63-71. [PMID: 26744578 DOI: 10.1016/j.job.2014.03.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND While the oral cavity harbors more than 680 bacterial species, the interaction and association of selected bacterial species play a role in periodontal diseases. Bacterial species including Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, a consortium previously designated as the "red complex" is now being expanded to include other new emerging pathogens that are significantly associated with periodontal disease. HIGHLIGHT In addition to novel mechanisms for oxidative resistance of individual species, community dynamics may lead to an overall strategy for survival in the inflammatory environment of the periodontal pocket. Complex systems controlled by response regulators protect against oxidative and nitrosative stress. CONCLUSION The combination of these multifaceted strategies would provide a comprehensive defense and support system against the repetitive host immune response to promote microbial persistence and disease.
Collapse
Affiliation(s)
- Leroy G Henry
- Division of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, California 92350
| | - Marie-Claire Boutrin
- Division of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, California 92350
| | - Wilson Aruni
- Division of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, California 92350
| | - Antonette Robles
- Division of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, California 92350
| | - Alexia Ximinies
- Division of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, California 92350
| | - Hansel M Fletcher
- Division of Microbiology and Molecular Genetics, School of Medicine, Loma Linda University, Loma Linda, California 92350
| |
Collapse
|
9
|
Bragazzi NL, Pechkova E, Nicolini C. Proteomics and Proteogenomics Approaches for Oral Diseases. ADVANCES IN PROTEIN CHEMISTRY AND STRUCTURAL BIOLOGY 2014; 95:125-62. [DOI: 10.1016/b978-0-12-800453-1.00004-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
|